172 related articles for article (PubMed ID: 23217102)
21. BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy.
Nathan FE; Berd D; Sato T; Shield JA; Shields CL; De Potter P; Mastrangelo MJ
J Exp Clin Cancer Res; 1997 Jun; 16(2):201-8. PubMed ID: 9261748
[TBL] [Abstract][Full Text] [Related]
22. [Effect of interferon alfa therapy on malignant melanoma of oral mucosa].
Liu YS; Zhang WD; Yang CH; Sun YF; Geng B
Shanghai Kou Qiang Yi Xue; 2006 Jun; 15(3):263-8. PubMed ID: 16862358
[TBL] [Abstract][Full Text] [Related]
23. Plasma levels of angiogenic factors and circulating endothelial cells in essential thrombocythemia: correlation with cytoreductive therapy and JAK2-V617F mutational status.
Treliński J; Wierzbowska A; Krawczyńska A; Sakowicz A; Pietrucha T; Smolewski P; Robak T; Chojnowski K
Leuk Lymphoma; 2010 Sep; 51(9):1727-33. PubMed ID: 20615083
[TBL] [Abstract][Full Text] [Related]
24. Circulating endothelial cells in patients with heart failure and left ventricular dysfunction.
Martínez-Sales V; Sánchez-Lázaro I; Vila V; Almenar L; Contreras T; Reganon E
Dis Markers; 2011; 31(2):75-82. PubMed ID: 21897001
[TBL] [Abstract][Full Text] [Related]
25. The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer.
Peng W; Liu YN; Zhu SQ; Li WQ; Guo FC
Cancer Med; 2018 Aug; 7(8):3773-3791. PubMed ID: 30003708
[TBL] [Abstract][Full Text] [Related]
26. Anti-angiogenic therapy in uveal melanoma.
El Filali M; Van der Velden PA; Luyten GPM; Jager MJ
Dev Ophthalmol; 2012; 49():117-136. PubMed ID: 22042017
[TBL] [Abstract][Full Text] [Related]
27. Serum interferon-related microRNAs as biomarkers to predict the response to interferon therapy in chronic hepatitis C genotype 4.
Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
PLoS One; 2015; 10(3):e0120794. PubMed ID: 25790297
[TBL] [Abstract][Full Text] [Related]
28. Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma.
Falkson CI
Med Oncol; 1995 Mar; 12(1):35-40. PubMed ID: 8542245
[TBL] [Abstract][Full Text] [Related]
29. Cisplatin and dacarbazine with or without subcutaneous interleukin-2 and interferon alfa-2b in advanced melanoma outpatients.
Koduri J; Baumann MA
J Clin Oncol; 2002 Aug; 20(16):3560; author reply 3560-1. PubMed ID: 12177119
[No Abstract] [Full Text] [Related]
30. [Safety and efficacy of interferon alfa-2b in the adjuvant treatment of uveal melanoma].
Richtig E; Langmann G; Schlemmer G; Müllner K; Papaefthymiou G; Bergthaler P; Smolle J
Ophthalmologe; 2006 Jun; 103(6):506-11. PubMed ID: 16763868
[TBL] [Abstract][Full Text] [Related]
31. Effects of interferon-alpha, verapamil and dacarbazine in the treatment of advanced malignant melanoma.
Andersson R; Ake Hofer P; Riklund-Ahlström K; Henriksson R
Melanoma Res; 2003 Feb; 13(1):87-91. PubMed ID: 12569290
[TBL] [Abstract][Full Text] [Related]
32. Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-{alpha}2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanoma.
Middleton M; Hauschild A; Thomson D; Anderson R; Burdette-Radoux S; Gehlsen K; Hellstrand K; Naredi P
Ann Oncol; 2007 Oct; 18(10):1691-7. PubMed ID: 17709802
[TBL] [Abstract][Full Text] [Related]
33. Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group.
Keilholz U; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; Thomas J; Proebstle TM; Schmittel A; Schadendorf D; Velu T; Negrier S; Kleeberg U; Lehman F; Suciu S; Eggermont AM
J Clin Oncol; 2005 Sep; 23(27):6747-55. PubMed ID: 16170182
[TBL] [Abstract][Full Text] [Related]
34. A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma.
O'Neill PA; Butt M; Eswar CV; Gillis P; Marshall E
Melanoma Res; 2006 Jun; 16(3):245-8. PubMed ID: 16718271
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.
Tabuchi T; Satoh M; Itoh T; Nakamura M
Clin Sci (Lond); 2012 Aug; 123(3):161-71. PubMed ID: 22364258
[TBL] [Abstract][Full Text] [Related]
36. Recombinant interferon alpha-2a in combination with dacarbazine in the treatment of metastatic malignant melanoma: analysis of long-term responding patients.
Ron IG; Inbar MJ; Gutman M; Merimsky O; Chaitchik S
Cancer Immunol Immunother; 1993 Jul; 37(1):61-6. PubMed ID: 8513453
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia.
Spinetti G; Fortunato O; Caporali A; Shantikumar S; Marchetti M; Meloni M; Descamps B; Floris I; Sangalli E; Vono R; Faglia E; Specchia C; Pintus G; Madeddu P; Emanueli C
Circ Res; 2013 Jan; 112(2):335-46. PubMed ID: 23233752
[TBL] [Abstract][Full Text] [Related]
38. Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy.
Lesinski GB; Kondadasula SV; Crespin T; Shen L; Kendra K; Walker M; Carson WE
J Natl Cancer Inst; 2004 Sep; 96(17):1331-42. PubMed ID: 15339971
[TBL] [Abstract][Full Text] [Related]
39. Angioregulatory microRNAs in breast cancer
Soheilifar MH; Masoudi-Khoram N; Madadi S; Nobari S; Maadi H; Keshmiri Neghab H; Amini R; Pishnamazi M
J Adv Res; 2022 Mar; 37():235-253. PubMed ID: 35499045
[TBL] [Abstract][Full Text] [Related]
40. Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2.
Ma C; Armstrong AW
J Dermatolog Treat; 2014 Oct; 25(5):401-8. PubMed ID: 23763243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
